In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
In our area, the spirit of adventure dwells, the stuff of which big events are made. This spirit of adventure is heir to the ...